2 Growth Stocks to Buy in January and Hold for the Next 10 Years

Palantir Technologies, whose shares are up ~169% over the past year, reported Q3 revenue growth of 63% year-over-year and an adjusted operating margin of 51%, closed a record $1.3 billion in total contract value with U.S. commercial customers (up 342% YoY), and benefits from a partnership with Nvidia; analysts forecast ~45% annualized EPS growth over the next several years. Rocket Lab, up ~271% year-over-year, posted Q3 revenue of $155 million (up 48% YoY), is targeting profitability by 2027 (consensus adjusted EPS $0.19) and projects revenue rising from ~$600 million in 2025 to $1.9 billion by 2029, with its larger, reusable Neutron rocket (28,700 lb payload) cited as a key growth and margin catalyst.

Analysis

Market structure: Winners include PLTR (enterprise AI software), RKLB (small-to-medium launch + Neutron upside), and ecosystem partners (NVDA, cloud infra) as spending shifts from bespoke engineering to AI-enabled SaaS. Losers are legacy, high-FCF aerospace contractors and low-margin analytics vendors as pricing power concentrates with platforms that deliver measurable cost savings (PLTR reported +63% YoY revenue and $1.3bn TCV in Q3). Demand signals: robust enterprise AI contracting and satellite launch demand tighten capacity for launch providers and GPU/cloud resources, amplifying volatility in options and duration sensitivity in IG bonds as growth re-rates.

Risk assessment: Tail risks—major launch failure for RKLB, loss of a top PLTR commercial/government client, or regulatory/privacy constraints—could wipe out 40–60% of implied upside in 6–18 months. Immediate (days): momentum and options-flow; short-term (weeks–months): quarterly results and first Neutron test; long-term (2–5 years): realization of the assumed 45% EPS CAGR for PLTR and RKLB reaching consensus revenue (600M→1.9B by 2029). Hidden dependencies include PLTR’s dependence on NVDA acceleration stack and RKLB’s supplier/engine production cadence; catalysts are large multi-year contract awards and a successful Neutron orbital flight.

Trade implications: Tactical ideas are asymmetric: buy optionality on RKLB via 12–18 month call spreads sized 1–2% of portfolio ahead of Neutron, and accumulate PLTR on >15–25% pullbacks to target 3–5x multi-year returns if growth sustains; use defined-loss options to cap downside. Implement a relative-value pair (long PLTR vs short IGV or a weaker AI/SaaS name) over 6–12 months to express confidence in platform margins versus broad software multiple compression. Rotate 1–3% from large aerospace (BA/LMT) into space infra exposure until Neutron proves reusability economics.

Contrarian angles: The market may be underestimating execution risk: PLTR’s 51% adjusted operating margin in Q3 relies on scalable, sticky revenue—if gross retention slips below 85% or YoY growth drops under 30% the multiple must contract materially. RKLB’s forward revenue trajectory (consensus 600M→1.9B) is binary—one successful Neutron sequence could re-rate shares; a >12-month delay could halve implied valuation. Historical parallel: early cloud winners outperformed after durability proved; many space IPOs failed pre-profitability—price accordingly and size positions for binary outcomes.

Key Decisions for Investors

• Establish a 2–3% long position in PLTR on a 15–25% pullback within the next 3 months; add incrementally to 5% if drawdown exceeds 35%. Set stop-loss at -30% absolute from entry or trim to half if quarterly revenue growth falls below 30% YoY or gross retention <85%.
• Buy RKLB asymmetric exposure via 12–18 month call spreads sized 1–2% of portfolio ahead of the Neutron test (expected within 6–18 months). Close on a successful orbital demonstration or cut if the maiden orbital attempt is delayed >12 months or a major test failure occurs.
• Implement a 6–12 month pair trade: long PLTR (2%) vs short IGV (1.5%) to capture relative-margin expansion; rebalance if PLTR underperforms IGV by >20% or if MSFT/NVDA signal broad enterprise AI slowdown.
• Reduce exposure to legacy aerospace/defense primes (BA, LMT) by 1–2% and reallocate to space infrastructure/launch exposure until market proves Neutron reusability; reassess after two consecutive successful Neutron flights or major commercial contract wins.